Coronavirus Drug Discovery -

Coronavirus Drug Discovery

Volume 2: Antiviral Agents from Natural Products and Nanotechnological Applications

Chukwuebuka Egbuna (Herausgeber)

Buch | Softcover
378 Seiten
2022
Elsevier - Health Sciences Division (Verlag)
978-0-323-95574-4 (ISBN)
218,20 inkl. MwSt
»Coronavirus Drug Discovery, Volume Two: Antiviral Agents from Natural Products and Nanotechnological Applications« presents detailed information on drug discovery against COVID-19. Sections in this volume present chapters that focus on the various antiviral agents from natural products that have the propensity to be used as chemical scaffolds for the development of drugs against COVID-19. Also captured are the dietary sources of antioxidant bioactives that may help boost the immune system for the management of COVID-19. Other chapters describe the application of nanotechnology for efficient and effective delivery of drugs against COVID-19.

Written by global team of experts, this book is an excellent resource for drug developers, medicinal chemists, pharmaceutical companies in R&D and research institutes in both academia and industry.

Chukwuebuka Egbuna is a chartered chemist, a chemical analyst, and an academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), the Society of Quality Assurance (SQA) (USA), and the Royal Society of Chemistry (RSC) (United Kingdom).
Egbuna is also an editor of new Elsevier series on Drug Discovery Update. The series includes books, monographs and edited collections from all areas of drug discovery, including emerging therapeutic claims for the treatment of diseases. He has been engaged in a number of roles at New Divine Favor Pharmaceutical Industry Limited, Akuzor Nkpor, Anambra State, Nigeria, and Chukwuemeka Odumegwu Ojukwu University (COOU) in Nigeria. He has collaboratively worked and published quite a number of research articles in the area of phytochemistry, nutrition and toxicology and related areas. He is a reviewer and editorial board member of various journals, including serving as a website administrator for the Tropical Journal of Applied Natural Sciences (TJANS), a journal of the faculty of Natural Sciences, COOU and as an advisory board member under toxicology for the book publisher, Cambridge Scholar Publishing. His primary research interests are in phytochemistry, nutrition and toxicology, food and medicinal chemistry, and analytical biochemistry.

PART I: ANTIVIRAL AGENTS FROM NATURAL PRODUCTS 1. COVID-19 management and phytomedicine interventions: Potentials and safety considerations 2. Plants with potent antiviral properties 3. Antiviral effects of medicinal plants and their active phytochemical constituents against respiratory diseases and associated biological functions 4. Herbs and drugs in clinical trials for coronavirus treatments 5. Herbal-Based Resources against Exanthematous Viral Infections and Other Viral Diseases 6. Dietary polyphenols as therapeutic agents to combat COVID-19 7. Bioactive compounds and herbal preparations implicated in for the treatment of SARS-CoV-2 8. Roles of Antioxidants in the Prevention and Management of Coronavirus Disease 2019 9. Food sources of natural antioxidants for body defence against SARS-CoV-2 10. Nutritional Management against Severe Acute Respiratory Syndrome Coronavirus-2 Infection

Erscheinungsdatum
Reihe/Serie Drug Discovery Update
Verlagsort Philadelphia
Sprache englisch
Maße 152 x 229 mm
Gewicht 450 g
Einbandart kartoniert
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie
Naturwissenschaften Chemie Organische Chemie
Technik Umwelttechnik / Biotechnologie
ISBN-10 0-323-95574-6 / 0323955746
ISBN-13 978-0-323-95574-4 / 9780323955744
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich